Potential Druggable Targets Identified in Acute Myeloid Leukemia

Ben Leach
Published: Thursday, Jul 18, 2013
Richard Wilson

Richard Wilson, PhD

Acute myeloid leukemia (AML) is potentially driven by at least one genetic mutation in nearly all cases, with a complex interaction of multiple genetic events contributing to the development of the disease, according to findings published in the The New England Journal of Medicine.

The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059-2074.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication